By Professor Naresh Kumar

Patents

Kumar N, 2007, Lactams, processes for preparing them, pharmaceutical compositions containing them, and their use as antibacterial agents, Patent No.

Kumar N, 2006, Production of Isoflavonoid dimers as therapeutic agents derivatives, Patent No.

Kumar N, 2005, Association of antimicrobial furanone/lactam compounds with surfaces and polymers, Patent No.

Kumar N, 2005, Preparation of halomethylene alkanones as regulators of bacterial signalling pathways, Patent No.

Preprints

Urmi UL; Attard S; Vijay AK; Willcox M; Kumar N; Islam S; Kuppusamy R, 2023, Antiviral Activity of Anthranilamide Peptidomimetics against Herpes Simplex Virus 1 and a Coronavirus, , http://dx.doi.org/10.20944/preprints202308.2017.v1

Gantier M; Ullah T; Johansen M; Balka K; Ambrose R; Gearing L; Wenholz D; Zeng J; Miemczyk S; Nguyen D; Venkatraman R; Dennis M; Alharbi A; Ellyard J; Wong W; Kile B; Vinuesa C; Kelly G; Hansbro P; Laczka O; De Nardo D; Hansbro N; Kumar N, 2022, Pharmacological inhibition of TBK1/IKKε blunts COVID-19 immunopathology, , http://dx.doi.org/10.21203/rs.3.rs-1336801/v1

Gautam S; Mawari G; Daga MK; Kumar N, 2021, A case report on uneventful anticoagulation and persistence of type1 respiratory failure post severe COVID-19 infection in a patient of Osler-Weber-Rendu Syndrome., , http://dx.doi.org/10.21203/rs.3.rs-941184/v1

Daga MK; Mawari G; Wasi S; Kumar N; Sharma U; Hussain M, 2021, Current Pattern and Clinico-Bacteriological Profile of Healthcare Associated Infections (HAI) in an ICU Setting: An Observational Study, , http://dx.doi.org/10.21203/rs.3.rs-874099/v1

Grunfeld DA; Jones AM; Sun J; Le ST; Pickford R; Huang Q; Manefield M; Kumar N; Lee M; O’Carroll D, Electrochemical Degradation of a Perfluoroalkyl Substance (Pfas) Using a Simple Activated Carbon Cathode, , http://dx.doi.org/10.2139/ssrn.4203122

Gadde S; Kleynhans A; Holien J; Bhadbhade M; Nguyen PLD; Mittra R; Carter D; Marshall G; Cheung B; Kumar N, Pyrimido[1,2-A]Benzimidazoles as Inhibitors of Oncoproteins Ubiquitin Specific Protease 5 and MYCN in the Childhood Cancer Neuroblastoma, , http://dx.doi.org/10.2139/ssrn.4283384

Back to profile page